-
[JW R&D] Installed ‘No. 1’ Blood Irradiator SANGRAY in Korea
2021-02-11 -
[JW R&D] JW Leading the Dream of Completely Conquering Atopic Dermatitis
2021-03-09 -
[JW R&D] JW starts up developing ‘innovative infusion solution plant facility’ jointly with public a
2021-03-09 -
[JW R&D] JW, ‘Receiving Attention’ as a Leader of Innovative New Drugs (First-in-Class)
2021-03-09 -
[JW R&D] Renal Anemia Treatment of JW Pharmaceutical, Achieved New Drug Approval in Japan
2021-03-09 -
[JW R&D]JW, Making a New History of Developing Innovative New Drugs (first-in-class) in Korea
2021-03-09 -
[JW R&D] JW, Installs an Innovative STAT3 Target Anticancer Drug Pipeline
2021-03-09 - More
Popular posts
Plan Story
PR
-
JW Pharmaceutical Collaborates with U.S.-Based Tempus AI to Develop Anti-Cancer Drugs Using Clinical Data and Organoids
-
JW Pharmaceutical Accelerates Development of Innovative Drugs with AI-Based R&D Integrated Platform ‘JWave’
-
JW Pharmaceutical Collaborates with Zebit to Develop Metabolic Disease Drugs Using Zebrafish as an Alternative Model
-
JW Pharmaceutical’s C&C Research Laboratories Selected for National New Drug Development Project for Prostate Cancer Treatment
-
JW Pharmaceutical Receives IND Approval for STAT3-Targeted Anticancer Drug ‘JW2286’
-
JW Pharmaceutical Demonstrates Superior Hair Follicle Formation and Hair Growth of ‘JW0061’ Compared to Existing Hair Loss Treatments
R&D
JW of the day